Your browser doesn't support javascript.
loading
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry.
Hetland, Merete Lund; Christensen, Ib Jarle; Tarp, Ulrik; Dreyer, Lene; Hansen, Annette; Hansen, Ib Tønder; Kollerup, Gina; Linde, Louise; Lindegaard, Hanne M; Poulsen, Uta Engling; Schlemmer, Annette; Jensen, Dorte Vendelbo; Jensen, Signe; Hostenkamp, Gisela; Østergaard, Mikkel.
Affiliation
  • Hetland ML; DANBIO Registry, Copenhagen University Hospital, Department of Rheumatology, Hvidovre, Denmark. merete.hetland@dadlnet.dk
Arthritis Rheum ; 62(1): 22-32, 2010 Jan.
Article in En | MEDLINE | ID: mdl-20039405
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Medication Adherence / Antibodies, Monoclonal Type of study: Prognostic_studies / Screening_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2010 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents / Medication Adherence / Antibodies, Monoclonal Type of study: Prognostic_studies / Screening_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Year: 2010 Type: Article